
    
      Previous clinical trials have tested KRX-0502 administered with food, in dialysis-dependent
      and NDD-CKD patients.

      This clinical trial will evaluate the safety and efficacy of KRX-0502 in treating iron
      deficiency anemia in anemic, stage III to V NDD-CKD patients in a new dosing regimen (without
      food).
    
  